Potential Use of Alpha-1 Anti-trypsin in the Covid-19 Treatment
- PMID: 33195215
- PMCID: PMC7644540
- DOI: 10.3389/fcell.2020.577528
Potential Use of Alpha-1 Anti-trypsin in the Covid-19 Treatment
Keywords: AAT activity; COVID-19; SARS-CoV-2; cytokine; inflammation; therapy.
References
-
- Anderson E. D., Thomas L., Hayflick J. S., Thomas G. (1993). Inhibition of HIV-1 gp160-dependent membrane fusion by a furindirected alpha 1-antitrypsin variant. J. Biol. Chem. 268, 24887–24891. - PubMed
-
- Arnaldez F. I., O'Day S. J., Drake C. G., Fox B. A., Fu B., Urba W. J., et al. . (2020). The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response. Version 2. J. Immunother. Cancer. 8:e000930. 10.1136/jitc-2020-000930 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous